These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 30184175)

  • 61. Comparative genomics of
    Felice AG; Santos LNQ; Kolossowski I; Zen FL; Alves LG; Rodrigues TCV; Prado LCS; Jaiswal AK; Tiwari S; Miranda FM; Ramos RTJ; Azevedo V; Oliveira CJF; Benevides LJ; Soares SC
    J Biomol Struct Dyn; 2022; 40(20):10136-10152. PubMed ID: 34155952
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pulsed-field gel electrophoresis analysis of Bordetella pertussis populations in various European countries with different vaccine policies.
    Caro V; Njamkepo E; Van Amersfoorth SC; Mooi FR; Advani A; Hallander HO; He Q; Mertsola J; Riffelmann M; Vahrenholz C; Von König CH; Guiso N
    Microbes Infect; 2005 Jun; 7(7-8):976-82. PubMed ID: 15994109
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Strain variation among Bordetella pertussis isolates in finland, where the whole-cell pertussis vaccine has been used for 50 years.
    Elomaa A; Advani A; Donnelly D; Antila M; Mertsola J; Hallander H; He Q
    J Clin Microbiol; 2005 Aug; 43(8):3681-7. PubMed ID: 16081896
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Plasticity of fimbrial genotype and serotype within populations of Bordetella pertussis: analysis by paired flow cytometry and genome sequencing.
    Vaughan TE; Pratt CB; Sealey K; Preston A; Fry NK; Gorringe AR
    Microbiology (Reading); 2014 Sep; 160(Pt 9):2030-2044. PubMed ID: 25028460
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Strain variation and antigenic divergence among Bordetella pertussis circulating strains isolated from patients in Iran.
    Sadeghpour Heravi F; Nikbin VS; Nakhost Lotfi M; Badiri P; Jannesar Ahmadi N; Zahraei SM; Shahcheraghi F
    Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1893-1900. PubMed ID: 30094521
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Rapid identification of Bordetella pertussis pertactin gene variants using LightCycler real-time polymerase chain reaction combined with melting curve analysis and gel electrophoresis.
    Mäkinen J; Viljanen MK; Mertsola J; Arvilommi H; He Q
    Emerg Infect Dis; 2001; 7(6):952-8. PubMed ID: 11747721
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Genetic variability of Bordetella pertussis strains. Part I. Current knowledge].
    Gzyl A; Augustynowicz E; Gniadek G; Slusarczyk J
    Przegl Epidemiol; 2003; 57(1):181-92. PubMed ID: 12926327
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Population dynamics of Bordetella pertussis in Finland and Sweden, neighbouring countries with different vaccination histories.
    Elomaa A; Advani A; Donnelly D; Antila M; Mertsola J; He Q; Hallander H
    Vaccine; 2007 Jan; 25(5):918-26. PubMed ID: 17030495
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Molecular genetic characteristics of the B. pertussis strains isolated in different periods of the pertussis epidemic process].
    Mazurova IK; Borisova OIu; Kombarova SIu; Zakharova NS; Aleshkin VA
    Mol Gen Mikrobiol Virusol; 2005; (4):21-5. PubMed ID: 16334221
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Genome-wide analysis of single nucleotide polymorphisms in Bordetella pertussis using comparative genomic sequencing.
    Maharjan RP; Gu C; Reeves PR; Sintchenko V; Gilbert GL; Lan R
    Res Microbiol; 2008; 159(9-10):602-8. PubMed ID: 18790049
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Outer membrane vesicles derived from Bordetella parapertussis as an acellular vaccine against Bordetella parapertussis and Bordetella pertussis infection.
    Bottero D; Gaillard ME; Errea A; Moreno G; Zurita E; Pianciola L; Rumbo M; Hozbor D
    Vaccine; 2013 Oct; 31(45):5262-8. PubMed ID: 24012570
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years.
    Weber C; Boursaux-Eude C; Coralie G; Caro V; Guiso N
    J Clin Microbiol; 2001 Dec; 39(12):4396-403. PubMed ID: 11724851
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Bordetella pertussis fimbriae (Fim): relevance for vaccines.
    Gorringe AR; Vaughan TE
    Expert Rev Vaccines; 2014 Oct; 13(10):1205-14. PubMed ID: 25102891
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Genetic and antigenic analysis of Bordetella pertussis isolates recovered from clinical cases in Ontario, Canada, before and after the introduction of the acellular pertussis vaccine.
    Tsang RS; Sill ML; Martin IE; Jamieson F
    Can J Microbiol; 2005 Oct; 51(10):887-92. PubMed ID: 16333349
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Phase variation and microevolution at homopolymeric tracts in Bordetella pertussis.
    Gogol EB; Cummings CA; Burns RC; Relman DA
    BMC Genomics; 2007 May; 8():122. PubMed ID: 17509142
    [TBL] [Abstract][Full Text] [Related]  

  • 76. First report and detailed characterization of B. pertussis isolates not expressing Pertussis Toxin or Pertactin.
    Bouchez V; Brun D; Cantinelli T; Dore G; Njamkepo E; Guiso N
    Vaccine; 2009 Oct; 27(43):6034-41. PubMed ID: 19666155
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Genotypic and phenotypic characterization of Bordetella pertussis strains used in different vaccine formulations in Latin America.
    Bottero D; Gaillard ME; Basile LA; Fritz M; Hozbor DF
    J Appl Microbiol; 2012 Jun; 112(6):1266-76. PubMed ID: 22471652
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Whole-genome sequencing and comparative genomic analysis of Bordetella pertussis isolates from the 2007-2008 epidemic in Israel.
    Octavia S; Wu SZ; Kaur S; Valinsky L; Marva E; Moran-Gilad J; Lan R
    J Infect; 2017 Feb; 74(2):204-207. PubMed ID: 27914992
    [No Abstract]   [Full Text] [Related]  

  • 79. Pertactin-Negative and Filamentous Hemagglutinin-Negative Bordetella pertussis, Australia, 2013-2017.
    Xu Z; Octavia S; Luu LDW; Payne M; Timms V; Tay CY; Keil AD; Sintchenko V; Guiso N; Lan R
    Emerg Infect Dis; 2019 Jun; 25(6):1196-1199. PubMed ID: 31107218
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Restriction analysis of Bordetella pertussis DNA isolated from patients with whooping cough in 1968 and 1995-98 and B. pertussis used for production of national vaccine strains].
    Chodorowska M; Kuklińska D
    Med Dosw Mikrobiol; 2000; 52(2):111-7. PubMed ID: 11107785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.